Trial Profile
The Efficacy and Safety of Continuous Administration of Endostar Combined With Chemotherapy for Patients With Advanced no Small Cell Lung Cancer: An Open-label, no Randomized Controlled Multicenter Phase II Study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Apr 2017 New trial record